Yifeng Pharmacy Chain Co., Ltd. (603939.SS)
CNY 25.67
(-0.62%)
CNY 25.67
(-0.62%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 4.04 Billion CNY | 8.92% |
| 2022 | 3.64 Billion CNY | 28.88% |
| 2021 | 2.69 Billion CNY | 96.69% |
| 2020 | 2.14 Billion CNY | 42.55% |
| 2019 | 954.81 Million CNY | 43.42% |
| 2018 | 661.28 Million CNY | 38.0% |
| 2017 | 493.15 Million CNY | 39.86% |
| 2016 | 402.6 Million CNY | 38.88% |
| 2015 | 246.63 Million CNY | 19.48% |
| 2014 | 206.32 Million CNY | 35.91% |
| 2013 | 154.47 Million CNY | 42.83% |
| 2012 | 108.15 Million CNY | 46.76% |
| 2011 | 74.59 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 1.04 Billion CNY | 0.0% |
| 2024 Q3 | 505.34 Million CNY | -54.29% |
| 2024 Q1 | 647.01 Million CNY | -100.0% |
| 2023 Q2 | 578.54 Million CNY | 5.21% |
| 2023 Q1 | 549.88 Million CNY | -22.49% |
| 2023 FY | - CNY | 8.92% |
| 2023 Q4 | 1.04 Billion CNY | 111.98% |
| 2023 Q3 | 492.52 Million CNY | -14.87% |
| 2022 Q4 | 709.4 Million CNY | 69.63% |
| 2022 Q3 | 418.2 Million CNY | -16.08% |
| 2022 Q2 | 498.32 Million CNY | 8.31% |
| 2022 Q1 | 460.07 Million CNY | 29.5% |
| 2022 FY | - CNY | 28.88% |
| 2021 Q2 | 436.26 Million CNY | 4.18% |
| 2021 FY | - CNY | 96.69% |
| 2021 Q1 | 418.77 Million CNY | 38.4% |
| 2021 Q3 | 334.89 Million CNY | -23.24% |
| 2021 Q4 | 355.26 Million CNY | 6.08% |
| 2020 Q2 | 359.61 Million CNY | 18.19% |
| 2020 Q3 | 313.48 Million CNY | -12.83% |
| 2020 Q4 | 302.59 Million CNY | -3.47% |
| 2020 FY | - CNY | 42.55% |
| 2020 Q1 | 304.27 Million CNY | 46.35% |
| 2019 Q4 | 207.91 Million CNY | 11.43% |
| 2019 Q1 | 237.21 Million CNY | 44.05% |
| 2019 FY | - CNY | 43.42% |
| 2019 Q2 | 249.64 Million CNY | 5.24% |
| 2019 Q3 | 186.57 Million CNY | -25.26% |
| 2018 Q4 | 164.67 Million CNY | 30.77% |
| 2018 FY | - CNY | 38.0% |
| 2018 Q3 | 125.93 Million CNY | -25.36% |
| 2018 Q2 | 168.7 Million CNY | 11.78% |
| 2018 Q1 | 150.93 Million CNY | -3.59% |
| 2017 FY | - CNY | 39.86% |
| 2017 Q1 | 88.07 Million CNY | -13.67% |
| 2017 Q2 | 105.99 Million CNY | 20.34% |
| 2017 Q3 | 92.4 Million CNY | -12.82% |
| 2017 Q4 | 156.55 Million CNY | 69.42% |
| 2016 Q2 | 80.31 Million CNY | 11.9% |
| 2016 Q3 | 60.73 Million CNY | -24.38% |
| 2016 Q4 | 102.02 Million CNY | 67.98% |
| 2016 FY | - CNY | 38.88% |
| 2016 Q1 | 71.77 Million CNY | 8.21% |
| 2015 Q4 | 66.32 Million CNY | 48.48% |
| 2015 Q3 | 44.67 Million CNY | -21.29% |
| 2015 Q2 | 56.75 Million CNY | -3.56% |
| 2015 Q1 | 58.84 Million CNY | -4.85% |
| 2015 FY | - CNY | 19.48% |
| 2014 Q1 | 45.3 Million CNY | 0.0% |
| 2014 FY | - CNY | 35.91% |
| 2014 Q4 | 61.84 Million CNY | 61.43% |
| 2014 Q3 | 38.31 Million CNY | -15.51% |
| 2014 Q2 | 45.34 Million CNY | 0.09% |
| 2013 FY | - CNY | 42.83% |
| 2012 FY | - CNY | 46.76% |
| 2011 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Shanghai No.1 Pharmacy Co., Ltd. | 186.51 Million CNY | -2070.663% |
| Jointown Pharmaceutical Group Co., Ltd | 5.08 Billion CNY | 20.358% |
| LBX Pharmacy Chain Joint Stock Company | 3.06 Billion CNY | -31.899% |
| Yunnan Jianzhijia Health-Chain Co., Ltd. | 1.53 Billion CNY | -163.069% |